Saturday, 7 July 2012

Sarcopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Sarcopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2018 report is an essential source of information and analysis on the global sarcopenia therapeutics market. The report identifies the key trends shaping and driving the global sarcopenia therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the global sarcopenia therapeutics sector.

Global Data estimates that the global sarcopenia therapeutics market was valued at $10.1m in 2010. The market is forecasted to witness a consistent growth with a Compound Annual Growth Rate (CAGR) of 9.6% in the next eight years and it is expected to reach $20.9m in the year 2018. This is inclusive of the markets of the US, the UK, Italy and Japan. The growth in the market is primarily attributed to increases in aging populations. The limited valuation of the market is due to the fact that drug therapy is not recommended as the first line treatment for sarcopenia. At present, no drug has been approved for treating sarcopenia. The current competitive landscape consists of only generic and off-label drugs such as testosterone, estrogen and growth hormones. In countries such as Germany, Spain and France, no pharmacological treatment is being prescribed for treating sarcopenia so these countries were not included when estimating the global sarcopenia therapeutics market. The treatment landscape is not going to witness any major change in the future due to lack of promising drugs in the late stage pipeline. The global sarcopenia market is expected to remain as a low value market during the forecast period due to the domination of off-label drugs.

Note: This is a on-demand report and will be delivered within 3 business days of the purchase (excluding weekends).


The report provides information on the key drivers and challenges of the sarcopenia therapeutics market. Its scope includes -
- Annualized global sarcopenia therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as androgen and growth hormones.
- Analysis of the current and future competition in the global sarcopenia therapeutics market. The key market player covered is GTx.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the sarcopenia therapeutics market.
- Analysis of key recent licensing and partnership agreements in sarcopenia theapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Sarcopenia therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Sarcopenia therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Sarcopenia therapeutics market landscape? – Identify, understand and capitalize.

To view a detailed table of contents for this market report please visit:

No comments:

Post a Comment